EAST - AFNET 4 an AFNET / EHRA Trial

EAST - AFNET 4
an AFNET e.V. / EHRA Trial

STUDY OBJECTIVE

The EAST trial tests whether an early, comprehensive, rhythm control therapy can prevent adverse cardiovascular outcomes in patients with atrial fibrillation (AF) compared to usual care.

Patient Recruitment ended on December 31, 2016. 2,789 patients have been enrolled. In toal, 168 study sites in 11 countries particpated in the EAST study.

 

The EAST - AFNET 4 trial is partially funded by the German Centre for Cardiovascular Research (DZHK)

 

GermanyBelgiumCzech RepublicFranceGreat BritainItalyNetherlandsPolandSpainSwitzerlandDenmark

 

EAST is registered at ClinicalTrials.gov, ISRTCN, and EU Clinical Trials Register

ClinicalTrials.gov: NCT01288352
http://clinicaltrials.gov/ct2/show/NCT01288352?term=NCT01288352&rank=1

ISRCTN04708680
http://www.controlled-trials.com/ISRCTN04708680

EU Clinical Trials Register
https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2010-021258-20